Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Joel Trugman, MD
Allergan
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
112 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Achieve Clinical Research, Llc
Birmingham, Alabama, United States
- Clinical Research Advantage, Inc./simon Williamson Clinic, Pc
Birmingham, Alabama, United States
- Synexus Clinical Research Us, Inc./east Valley Family Physicians Plc
Chandler, Arizona, United States
- Synexus Clinical Research Us, Inc./desert Clinical Research, Llc
Mesa, Arizona, United States
- Synexus Clinical Research Us, Inc./central Phoenix Medical Clinic, Llc
Phoenix, Arizona, United States
- Anaheim Clinical Trials, Llc
Anaheim, California, United States
- Hope Clinical Research
Canoga Park, California, United States
- Pharmacology Research Institute
Encino, California, United States
- Sun Valley Research Center, Inc.
Imperial, California, United States
- Irvine Center for Clinical Research
Irvine, California, United States
- Grossmont Center for Clinical Research
La Mesa, California, United States
- Synergy San Diego
Lemon Grove, California, United States
- Collaborative Neuroscience Network, Llc.
Long Beach, California, United States
- Pharmacology Research Institute
Los Alamitos, California, United States
- Pacific Research Partners, Llc
Oakland, California, United States
- Excell Research, Inc.
Oceanside, California, United States
- Desert Valley Research
Redlands, California, United States
- California Research Foundation
San Diego, California, United States
- Medical Center for Clinical Research
San Diego, California, United States
- Artemis Institute for Clinical Research
San Marcos, California, United States
- California Medical Clinic for Headache
Santa Monica, California, United States
- Encompass Clinical Research
Spring Valley, California, United States
- Synexus Clinical Research Us, Inc.
Vista, California, United States
- Diablo Clinical Research, Inc
Walnut Creek, California, United States
- Delta Waves, Inc.
Colorado Springs, Colorado, United States
- Advanced Neurosciences Research, Llc
Fort Collins, Colorado, United States
- Md Clinical
Hallandale, Florida, United States
- Infinity Clinical Research
Hollywood, Florida, United States
- Clinical Neuroscience Solutions
Jacksonville, Florida, United States
- Health Awareness, Inc.
Jupiter, Florida, United States
- Meridien Research
Maitland, Florida, United States
- Well Pharma Medical Research, Corp.
Miami, Florida, United States
- Sensible Healthcare Llc
Ocoee, Florida, United States
- Bioclinica Research
Orlando, Florida, United States
- Clinical Neuroscience Solutions, Inc
Orlando, Florida, United States
- Infinity Clinical Research Llc
Sunrise, Florida, United States
- Meridien Research
Tampa, Florida, United States
- Palm Beach Research Center
West Palm Beach, Florida, United States
- Premiere Research Institute
West Palm Beach, Florida, United States
- Atlanta Center for Clinical Research
Atlanta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Oct 2018
- Primary completion
- 21 May 2020
- Completion
- 21 May 2020
- Last update posted
- 15 Jun 2021
- Registered enrollment
- 744
- Registry id
- NCT03700320
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.